Floxuridine Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-145

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Floxuridine (NDC 63323-145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Fklz Address)

FDA Label Image

Carton (Floxuridine Carton)

Floxuridine for Injection, USP 500 mg per vial label for intra-arterial use only. Indicates the product is a powder for reconstitution of parenteral solutions. Label includes Fresenius Kabi logo and states Rx only.*

FDA Label Image

Floxuridine-structure (Floxuridine For Injection Usp Figure 1 Floxuridine Structure)

Chemical structure diagram of the active ingredient floxuridine, showing the molecular formula C9H11FN2O5 and molecular weight 246.19.*

FDA Label Image

Vial (Floxuridine Vial)

Floxuridine for Injection, USP 500 mg per vial. Lyophilized powder for reconstitution of parenteral solutions, intended for intra-arterial use only. Label includes storage instructions: store powder at 20° to 25°C and reconstituted vial under refrigeration (2° to 8°C) for no more than 2 weeks. Labeler is Fresenius Kabi USA, LLC. Contains manufacturer and product details alongside a barcode and lot/expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.